Comparison of Breast Reconstruction Strategies Using Exclusive Lipofilling or Prosthesis After Total Mastectomy for Breast Cancer: Satisfaction and Morbidity After More Than 2 Years

医学 乳房再造术 乳腺癌 假肢 乳房切除术 患者满意度 外科 多元分析 回顾性队列研究 乳房整形术 癌症 内科学
作者
Matthieu Beque,Gabrielle Aubry,Jean-Christophe Bichet,Catherine Uzan,Geoffroy Canlorbe
出处
期刊:Aesthetic Surgery Journal [Oxford University Press]
标识
DOI:10.1093/asj/sjaf174
摘要

Abstract Background Total mastectomy for breast cancer is an impactful procedure, and breast reconstruction plays a crucial role for women diagnosed with the disease. Objectives The objective of our study is to compare satisfaction, morbidity, and timelines of two breast reconstruction techniques after breast cancer: breast prosthesis and exclusive lipofilling. Methods This is a comparative, retrospective, unicentric study on patients who underwent total mastectomy between May 2014 and May 2020. Satisfaction is assessed using the BREAST-Q questionnaire at least 2 years after the start of the reconstruction (4.8 (± 0.16) years in the implant group and 5.4 (± 0.12) years the lipofilling group, p value = 0.044). Morbidity is evaluated using the Clavien-Dindo classification Results One hundred and one patients were included in the study (60 in the prosthesis group and 41 in the lipofilling group). The response rate to the questionnaire was 63.3% (38 patients) in the prosthesis group and 70.7% (29 patients) in the lipofilling group. The lipofilling technique appears to provide better satisfaction for the “sexual well-being” item of the BREAST-Q in multivariate analysis (65.75 +/-1.92 versus 54.87 +/-1.46, multivariate p-value = 0.03). Major complication (grade III, IV or V) rate was 20% in the prosthesis reconstruction group compared to 0% in the lipofilling group (multivariate p-value = 0.05). Lipofilling often requires longer reconstruction times, but reoperations are more frequent in prosthesis reconstruction, extending the reconstruction periods. Conclusions Our data should be confirmed by other studies to better guide the choice of reconstruction type.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Jiaxx发布了新的文献求助30
刚刚
李小聪完成签到,获得积分10
1秒前
富婆阳西发布了新的文献求助40
2秒前
猪猪hero发布了新的文献求助30
5秒前
赘婿应助sun采纳,获得10
5秒前
科研通AI6应助滴滴滴采纳,获得10
6秒前
6秒前
Acid完成签到 ,获得积分10
7秒前
一个小胖子完成签到,获得积分10
7秒前
科研通AI6应助难过的谷芹采纳,获得10
8秒前
ogriv完成签到,获得积分10
9秒前
WEIJIE_LI完成签到,获得积分10
11秒前
12秒前
13秒前
14秒前
mengq发布了新的文献求助30
15秒前
15秒前
高贵黄豆完成签到,获得积分10
16秒前
雨声完成签到,获得积分10
16秒前
tianzml0应助2224536采纳,获得10
16秒前
Special077发布了新的文献求助10
17秒前
asdf1234q1发布了新的文献求助10
19秒前
小马甲应助雨禾采纳,获得10
19秒前
远昼发布了新的文献求助10
21秒前
科研通AI5应助WEIJIE_LI采纳,获得10
21秒前
xiaoying在奋斗完成签到,获得积分10
22秒前
彭于晏应助LJQ采纳,获得10
22秒前
皇晃煌发布了新的文献求助30
22秒前
22秒前
Special077完成签到,获得积分10
23秒前
23秒前
啊啊完成签到,获得积分10
23秒前
蜉蝣应助欢城采纳,获得10
24秒前
木已成风完成签到,获得积分20
24秒前
24秒前
24秒前
25秒前
彭于晏应助合适台灯采纳,获得10
25秒前
27秒前
27秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
줄기세포 생물학 1000
The Netter Collection of Medical Illustrations: Digestive System, Volume 9, Part III - Liver, Biliary Tract, and Pancreas (3rd Edition) 600
中国减肥产品行业市场发展现状及前景趋势与投资分析研究报告(2025-2030版) 500
《2024-2029年中国减肥产品行业市场分析及发展前景预测报告》 500
A new house rat (Mammalia: Rodentia: Muridae) from the Andaman and Nicobar Islands 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4508013
求助须知:如何正确求助?哪些是违规求助? 3955427
关于积分的说明 12262170
捐赠科研通 3615676
什么是DOI,文献DOI怎么找? 1989357
邀请新用户注册赠送积分活动 1025789
科研通“疑难数据库(出版商)”最低求助积分说明 917324